[["objective-4.html", "Chapter 5 Objective 4 5.1 CST ordering 5.2 Proportion of culture rest results available at the PPS day 5.3 Missed doses", " Chapter 5 Objective 4 Objective 4. To assess use and availability of laboratory diagnostics services to support antibiotic prescriptions for hospitalized patients in Kenya 5.1 CST ordering CST ordering practice KNH (N=504) CGTRH (N=175) JOOTRH (N=199) Machakos (N=169) MTRH (N=256) NPGH (N=167) Thika (N=220) Total (N=1690) p value No. of patients on antibiotics 216 (43%) 77 (47%) 93 (49%) 85 (50%) 128 (52%) 86 (51%) 92 (44%) 777 (47%) 0.159 Culture and Sensitivity test ordered &lt; 0.001 No 396 (79%) 151 (92%) 167 (88%) 159 (94%) 205 (84%) 166 (99%) 204 (99%) 1448 (88%) Yes 108 (21%) 13 (8%) 23 (12%) 10 (6%) 39 (16%) 1 (1%) 3 (1%) 197 (12%) Number of CST ordered 0.021 1 64 (59%) 6 (46%) 22 (96%) 10 (100%) 28 (72%) 1 (100%) 3 (100%) 134 (68%) 2 34 (31%) 5 (38%) 1 (4%) 0 (0%) 6 (15%) 0 (0%) 0 (0%) 46 (23%) 3 10 (9%) 2 (15%) 0 (0%) 0 (0%) 5 (13%) 0 (0%) 0 (0%) 17 (9%) 5.2 Proportion of culture rest results available at the PPS day CST results No of CST ordered (N=197) Culture results available (N=221) Specimen Types Blood 102 (52%) 47 (21%) Cerebrospinal fluid 23 (12%) 28 (13%) Joint aspirate 2 (1%) 2 (1%) Peritoneal fluid 1 (1%) 0 (0%) Pleural fluid 3 (2%) 4 (2%) Pus swab 55 (28%) 76 (34%) Stool 10 (5%) 10 (5%) Tissue 8 (4%) 12 (5%) Tracheal aspirate 17 (9%) 38 (17%) Urine 45 (23%) 77 (35%) Other 11 (6%) 17 (8%) 5.3 Missed doses 5.3.1 Kenyatta National Hospital Missed doses_KNH No (N=171) Yes (N=45) Total (N=216) p value Sex 0.075 Female 92 (54%) 16 (36%) 108 (50%) Male 78 (46%) 29 (64%) 107 (50%) Age Group 0.029 Adult (≥ 18 Years) 92 (54%) 15 (33%) 107 (50%) Child (≥ 1 and ≤ 17 Years) 31 (18%) 7 (16%) 38 (18%) Infant (≥ 1 and ≤ 11 Months) 15 (9%) 8 (18%) 23 (11%) Neonate (≤ 28 Days) 33 (19%) 15 (33%) 48 (22%) Ward 0.104 Critical Care Unit 6 (4%) 0 (0%) 6 (3%) Medicine 34 (20%) 5 (11%) 39 (18%) Obs Gynae 26 (15%) 3 (7%) 29 (13%) Pediatrics 64 (37%) 25 (56%) 89 (41%) special Units 3 (2%) 0 (0%) 3 (1%) Surgery (General) 16 (9%) 2 (4%) 18 (8%) Surgery (Ortho) 10 (6%) 4 (9%) 14 (6%) Surgery (Special) 12 (7%) 6 (13%) 18 (8%) Route of administration 0.181 Intravenous 117 (68%) 37 (82%) 154 (71%) Oral 53 (31%) 8 (18%) 61 (28%) Other 1 (1%) 0 (0%) 1 (0%) 5.3.2 Machakos Hospital Missed doses_Machakos No (N=61) Yes (N=24) Total (N=85) p value Sex 0.402 Female 32 (52%) 15 (62%) 47 (55%) Male 29 (48%) 9 (38%) 38 (45%) Age Group 0.103 Adult (≥ 18 Years) 39 (64%) 19 (79%) 58 (68%) Child (≥ 1 and ≤ 17 Years) 1 (2%) 2 (8%) 3 (4%) Infant (≥ 1 and ≤ 11 Months) 5 (8%) 0 (0%) 5 (6%) Neonate (≤ 28 Days) 16 (26%) 3 (12%) 19 (22%) Wards 0.230 Gynaecology 1 (2%) 2 (8%) 3 (4%) ICU 0 (0%) 1 (4%) 1 (1%) Maternity 15 (25%) 4 (17%) 19 (22%) Medical 10 (16%) 3 (12%) 13 (15%) NBU 16 (26%) 3 (12%) 19 (22%) Orthopedics 7 (11%) 3 (12%) 10 (12%) Other 2 (3%) 2 (8%) 4 (5%) Paediatrics 5 (8%) 1 (4%) 6 (7%) Surgical 5 (8%) 5 (21%) 10 (12%) Route of administration 0.663 Intramuscular 1 (2%) 0 (0%) 1 (1%) Intravenous 51 (84%) 19 (79%) 70 (82%) Oral 9 (15%) 5 (21%) 14 (16%) 5.3.3 Nakuru Provincial General Hospital Missed doses__NPGH No (N=69) Yes (N=17) Total (N=86) p value Sex 0.855 Female 43 (62%) 11 (65%) 54 (63%) Male 26 (38%) 6 (35%) 32 (37%) Age Group 0.335 Adult (≥ 18 Years) 45 (65%) 13 (76%) 58 (67%) Child (≥ 1 and ≤ 17 Years) 8 (12%) 3 (18%) 11 (13%) Infant (≥ 1 and ≤ 11 Months) 5 (7%) 1 (6%) 6 (7%) Neonate (≤ 28 Days) 11 (16%) 0 (0%) 11 (13%) Ward 0.047 ENT 0 (0%) 1 (6%) 1 (1%) ICU 2 (3%) 0 (0%) 2 (2%) Medical 12 (17%) 4 (24%) 16 (19%) NBU 8 (12%) 0 (0%) 8 (9%) Obs Gynae 19 (28%) 3 (18%) 22 (26%) Orthopedics 9 (13%) 2 (12%) 11 (13%) Paediatric 12 (17%) 1 (6%) 13 (15%) Surgical 7 (10%) 6 (35%) 13 (15%) Route of administration 0.541 Intravenous 52 (75%) 14 (82%) 66 (77%) Oral 17 (25%) 3 (18%) 20 (23%) 5.3.4 Thika Hospital Missed doses_Thika No (N=69) Yes (N=17) Total (N=86) p value Sex 0.855 Female 43 (62%) 11 (65%) 54 (63%) Male 26 (38%) 6 (35%) 32 (37%) Age Group 0.335 Adult (≥ 18 Years) 45 (65%) 13 (76%) 58 (67%) Child (≥ 1 and ≤ 17 Years) 8 (12%) 3 (18%) 11 (13%) Infant (≥ 1 and ≤ 11 Months) 5 (7%) 1 (6%) 6 (7%) Neonate (≤ 28 Days) 11 (16%) 0 (0%) 11 (13%) Ward 0.009 Gynaecology 19 (31%) 3 (19%) 22 (29%) Maternity 1 (2%) 5 (31%) 6 (8%) Medical 12 (20%) 4 (25%) 16 (21%) NBU 6 (10%) 1 (6%) 7 (9%) Other 2 (3%) 0 (0%) 2 (3%) Paediatrics 4 (7%) 1 (6%) 5 (6%) Surgical 17 (28%) 2 (12%) 19 (25%) Route of administration 0.541 Intravenous 52 (75%) 14 (82%) 66 (77%) Oral 17 (25%) 3 (18%) 20 (23%) 5.3.5 Coast General Teaching and Refferal Hospital Missed doses_CGTRH No (N=60) Yes (N=17) Total (N=77) p value Sex 0.520 Female 30 (50%) 7 (41%) 37 (48%) Male 30 (50%) 10 (59%) 40 (52%) Age Group 0.423 Adult (≥ 18 Years) 33 (55%) 8 (47%) 41 (53%) Child (≥ 1 and ≤ 17 Years) 10 (17%) 1 (6%) 11 (14%) Infant (≥ 1 and ≤ 11 Months) 3 (5%) 1 (6%) 4 (5%) Neonate (≤ 28 Days) 14 (23%) 7 (41%) 21 (27%) Route of administration 0.324 Intravenous 51 (85%) 16 (94%) 67 (87%) Oral 9 (15%) 1 (6%) 10 (13%) 5.3.6 Jaramogi Oginga Odinga Teaching and Refferal Hospital Missed doses_JOOTRH No (N=67) Yes (N=26) Total (N=93) p value Sex 0.554 Female 42 (63%) 18 (69%) 60 (65%) Male 25 (37%) 8 (31%) 33 (35%) Age Group 0.463 Adult (≥ 18 Years) 42 (63%) 14 (54%) 56 (60%) Child (≥ 1 and ≤ 17 Years) 14 (21%) 4 (15%) 18 (19%) Infant (≥ 1 and ≤ 11 Months) 5 (7%) 3 (12%) 8 (9%) Neonate (≤ 28 Days) 6 (9%) 5 (19%) 11 (12%) Route of administration 0.315 Intravenous 53 (79%) 18 (69%) 71 (76%) Oral 14 (21%) 8 (31%) 22 (24%) 5.3.7 Moi Teaching and Referral Hospital Missed doses_MTRH No (N=117) Yes (N=11) Total (N=128) p value Sex 0.752 Female 59 (50%) 5 (45%) 64 (50%) Male 58 (50%) 6 (55%) 64 (50%) Age Group 0.962 Adult (≥ 18 Years) 61 (52%) 6 (55%) 67 (52%) Child (≥ 1 and ≤ 17 Years) 34 (29%) 3 (27%) 37 (29%) Infant (≥ 1 and ≤ 11 Months) 7 (6%) 1 (9%) 8 (6%) Neonate (≤ 28 Days) 15 (13%) 1 (9%) 16 (12%) Route of administration 0.804 Intravenous 92 (79%) 9 (82%) 101 (79%) Oral 25 (21%) 2 (18%) 27 (21%) "]]
